Skip to content

LOCRAD: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

LOCRAD

BE 0464.466.880
NACE 46.460, Wholesale of pharmaceutical and medical goods
NACE division 46, Wholesale trade all sizesfiscal years 2020 to 20243,781 to 30,483 sector peers per ratio

Summary

fiscal year 2024

LOCRAD does better than half of its sector on 10 of the 11 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Solvencybetter than 95%
  • Current ratiobetter than 95%
  • Working-capital ratiobetter than 95%
Points to watch
  • Return on equitybetter than 35%

Solvency and debt

How soundly the company is financed.
Solvency
96.7%=2024

Solvency is above 95% of 30,385 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Debt to equity
0.03▲2024

Debt to equity is below 84% of 30,144 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Interest coverage
247.18▲2024

Interest coverage is above 93% of 26,470 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024

Liquidity

Whether it can pay its short-term bills.
Current ratio
27.94▼2024

The current ratio is above 95% of 30,118 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Working-capital ratio
89.3%▲2024

The working-capital ratio is above 95% of 30,335 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024

Profitability

What the company earns on its assets and its sales.
Return on equity
4.0%▲2024

Return on equity is below 65% of 26,212 sector peers: less favourable than the median.

Position against the sector improving since 2020.

20202021202220232024
Return on assets
3.9%▲2024

Return on assets is above 52% of 30,483 sector peers: more favourable than the median.

Position against the sector improving since 2020.

20202021202220232024
Net margin
41.2%▲2024

The net margin is above 95% of 4,200 sector peers: in the most favourable quarter.

Position against the sector improving since 2020.

20202021202220232024
EBITDA margin
63.8%▲2024

The EBITDA margin is above 95% of 3,781 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Gross margin
75.2%2024

The gross margin is above 95% of 4,058 sector peers: in the most favourable quarter.

20202021202220232024

Working-capital cycle

How long cash is tied up in customers, suppliers and stock.
Days sales outstanding
15days▼2024

Days sales outstanding is below 86% of 4,159 sector peers: in the most favourable quarter.

Position against the sector improving since 2020.

20202021202220232024
Days payable outstanding
205days2024

Days payable outstanding is above 91% of 4,181 sector peers.

20202021202220232024

Not computable

Long-term debt ratio, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.